# Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI

> **NCT03017287** · NA · TERMINATED · sponsor: **GlucoMe** · enrollment: 40 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1 or 2

## Interventions

- **DEVICE:** GlucoMe App

## Key facts

- **NCT ID:** NCT03017287
- **Lead sponsor:** GlucoMe
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2017-05
- **Final completion:** 2017-08
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2020-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017287, "Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03017287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
